ArticleAesthetic plastic surgery2026
Dual-Surface Epicanthoplasty for Conservative-to-Moderate Medial Canthal Opening in East Asian Eyelids.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpicanthoplasty aims to improve medial canthal exposure while minimizing visible scarring and postoperative tension. This study describes Dual-Surface Epicanthoplasty, a dual-surface technique for conservative-to-moderate medial canthal opening in East Asian eyelids, guided by a three-dimensional fold-unit concept that coordinates external cutaneous redraping with internal fold turning-point reconstruction.
methodsThis retrospective study included 80 patients (140 eyes) with clinically evident epicanthal folds and limited medial canthal exposure treated between February 2023 and April 2025. Outcomes were analyzed at the patient level using averaged bilateral values when applicable. Patients were categorized by surgical laterality and procedure type, and exploratory subgroup analyses compared isolated epicanthoplasty with epicanthoplasty combined with upper blepharoplasty. Morphologic outcomes included visible lacrimal lake width (VLLW), normalized VLLW, and exploratory intraoperative medial canthal fold depth (MCFD). Secondary outcomes included scar visibility, patient satisfaction, and complications.
resultsMean follow-up was 11.9 ± 2.8 months. VLLW increased from 1.47 ± 0.71 mm to 3.38 ± 0.34 mm, and normalized VLLW increased from 0.128 ± 0.060 to 0.299 ± 0.027 (both p < 0.001). MCFD decreased from 3.43 ± 0.26 mm before deep release to 2.68 ± 0.25 mm after D-A key suturing (p < 0.001). Median scar visibility score was 0 (IQR, 0-0), and median satisfaction score was 5 (IQR, 4-5). Hypertrophic scarring occurred unilaterally in 3 patients (3.8%), all within the asymmetry-revision subgroup. Interocular medial canthal asymmetry requiring unilateral revision occurred in 4 patients (5.0%).
conclusionsDual-Surface Epicanthoplasty may be feasible for selected East Asian patients seeking conservative-to-moderate medial canthal opening and was associated with increased lacrimal lake exposure, reduced exploratory intraoperative fold depth, low scar visibility, and high satisfaction. Controlled studies with reliability testing and longer follow-up are needed. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42897243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.